Showing results (161-170 of 192) with videos related to
Sort By:
Pageof 20
Neuro-Oncology|January 29, 2014
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, et al.Cell Genomics|May 24, 2024
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcomeH Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.Brain Pathology (Zurich, Switzerland)|March 5, 2013
Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous systemAditya Raghunathan, Khalida Wani, Terri S Armstrong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant GliomaFrederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, et al.Cancers|June 19, 2024
Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based ApproachDu Wang, Huaizhi Geng, Vinai Gondi, et al.The Journal of Clinical Investigation|December 25, 2010
Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaFernanda I Staquicini, Michael G Ozawa, Catherine A Moya, et al.Neuro-Oncology|February 13, 2021
Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6qLorena V Baroni, Lakshmikirupa Sundaresan, Ayala Heled, et al.Neuro-Oncology|July 18, 2020
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study designKurt A Jaeckle, Karla V Ballman, Martin van den Bent, et al.Clinical Chemistry|January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumorsKen Chen, Funda Meric-Bernstam, Hao Zhao, et al.The New England Journal of Medicine|February 21, 2014
A randomized trial of bevacizumab for newly diagnosed glioblastomaMark R Gilbert, James J Dignam, Terri S Armstrong, et al.Pageof 20